# usc-section 42 U.S.C. 285o-4

IRI: <https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cfbbc0d67f1>

Type: [adms:Identifier](http://www.w3.org/ns/adms#Identifier)

- `dcterms:conformsTo`: [usc-section](https://ontology.bommaritollc.com/vocab/scheme/usc-section)
- `prov:wasDerivedFrom`: [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title42/USCODE-2024-title42-chap6A-subchapIII-partC-subpart15-sec285o-4](https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cece435f8cb)
- `skos:notation`: 42 U.S.C. 285o-4

## Elsewhere

- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title42/USCODE-2024-title42-chap6A-subchapIII-partC-subpart15-sec285o-4) (www.govinfo.gov)

## Pointing here

- Its identifier, from (1; `adms:identifier`):
  - [42 U.S.C. 285o-4 Medication Development Program](https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cedd5f8ee6e)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cfbbc0d67f1.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cfbbc0d67f1.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cfbbc0d67f1.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cfbbc0d67f1)
Cite as: usc-section 42 U.S.C. 285o-4. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f07c-dafb-75c3-91ae-0cfbbc0d67f1
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
